Zobrazeno 1 - 10
of 177
pro vyhledávání: '"Ricardo, Restrepo"'
Publikováno v:
Antípoda: Revista de Antropología y Arqueología, Vol 55, Pp 65-87 (2024)
This article analyzes an Embera myth from northwest Colombia that sheds light on the origin of racial disparities and the poverty experienced by indigenous communities in comparison to “whites.” Methodologically, the myth was collected using ethn
Externí odkaz:
https://doaj.org/article/ae43ceeebc8b4ce4adfe5976a94bc325
Autor:
Nick H. Kim, Kelly M. Chin, Vallerie V. McLaughlin, Hilary DuBrock, Ricardo Restrepo-Jaramillo, Zeenat Safdar, Gwen MacDonald, Nicolas Martin, Daniel Rosenberg, Maria Solonets, Richard Channick
Publikováno v:
Pulmonary Therapy, Vol 10, Iss 1, Pp 85-107 (2024)
Abstract Introduction Portopulmonary hypertension (PoPH) carries a worse prognosis than other forms of pulmonary arterial hypertension (PAH). Data regarding use of PAH-specific therapies in patients with PoPH are sparse as they are usually excluded f
Externí odkaz:
https://doaj.org/article/d2d527f021da4bc98cd27bae7d4bdc4e
Autor:
Ricardo Restrepo Echavarría, John Antón Sánchez, Jesús Tapia López, Francisco Martínez Ortega
Publikováno v:
Perfiles Latinoamericanos, Vol 31, Iss 62 (2023)
Este artículo describe una investigación realizada para conocer si hay un impacto discriminatorio del covid-19 en las comunidades afrodescendientes del Ecuador, y qué le corresponde hacer al Estado, tomando en cuenta las necesidades y demandas de
Externí odkaz:
https://doaj.org/article/1f5730df3bfc45bfb529ae4d82ef5c92
Autor:
Shelley Shapiro, Stacy Mandras, Ricardo Restrepo‐Jaramillo, Eric Shen, Meredith Broderick, Youlan Rao, Dasom Lee, Andrew C. Nelsen
Publikováno v:
Pulmonary Circulation, Vol 11, Iss 4, Pp 1-7 (2021)
Treprostinil is a prostacyclin approved for the treatment of pulmonary arterial hypertension. Commercial data sets indicate that approximately 20–25% of patients are prescribed a higher dose than the maximum recommended dosage of nine breaths per t
Externí odkaz:
https://doaj.org/article/1be592dc6588428eabbfca9ed2a96c28
Publikováno v:
Iteckne, Vol 18, Iss 1, Pp 57-70 (2021)
Abiotic factors can negatively or positively affect the structure of communities; studying these factors is important to identify the causes that structure ant communities; taking into account this situation and that in the Amazon foothills region, p
Externí odkaz:
https://doaj.org/article/cc6683e5f09048368d3ed6234b9196e5
Autor:
Franck F. Rahaghi, Vijay P. Balasubramanian, Robert C. Bourge, Charles D. Burger, Murali M. Chakinala, Michael S. Eggert, Jean M. Elwing, Jeremy Feldman, Christopher King, James R. Klinger, Stephen C. Mathai, John Wesley McConnell, Harold I. Palevsky, Ricardo Restrepo‐Jaramillo, Zeenat Safdar, Jeffrey S. Sager, Namita Sood, Roxana Sulica, R. James White, Nicholas S. Hill
Publikováno v:
Pulmonary Circulation, Vol 12, Iss 2, Pp n/a-n/a (2022)
Abstract Dual combination therapy with a phosphodiesterase‐5 inhibitor (PDE5i) and endothelin receptor antagonist is recommended for most patients with intermediate‐risk pulmonary arterial hypertension (PAH). The RESPITE and REPLACE studies sugge
Externí odkaz:
https://doaj.org/article/9f5b66c79cd442eda20ab75c66cf4ff1
Autor:
Leslie A. Spikes, Abubakr A. Bajwa, Charles D. Burger, Sapna V. Desai, Michael S. Eggert, Karim A. El‐Kersh, Micah R. Fisher, Shilpa Johri, Joanna M. Joly, Jinesh Mehta, Harold I. Palevsky, Gautam V. Ramani, Ricardo Restrepo‐Jaramillo, Sandeep Sahay, Trushil G. Shah, Chunqin Deng, Melissa Miceli, Peter Smith, Shelley M. Shapiro
Publikováno v:
Pulmonary Circulation, Vol 12, Iss 2, Pp n/a-n/a (2022)
Abstract Inhaled treprostinil is an approved therapy for pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease in the United States. Studies have confirmed the robust benefits and safety of nebuliz
Externí odkaz:
https://doaj.org/article/54bf8d2f543344f38ef9f1658923dfa4
Autor:
Mauricio Orozco‐Levi, Jorge Cáneva, Caio Fernandes, Ricardo Restrepo‐Jaramillo, Nayeli Zayas, Rafael Conde, Mirta Diez, Carlos Jardim, Manuel C. Pacheco Gallego, Luciano Melatini, Héctor Valdéz, Tomás Pulido
Publikováno v:
Pulmonary Circulation, Vol 12, Iss 1, Pp n/a-n/a (2022)
Abstract Treatment for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in Latin America differs between countries, with regard to disease etiology, health insurance coverage, and drug availability. A group of experts
Externí odkaz:
https://doaj.org/article/0d708ba3098c416781382fb49ae78e18
Autor:
Debabrata Bandyopadhyay, Christopher Lai, Juan N. Pulido, Ricardo Restrepo-Jaramillo, Adriano R. Tonelli, Marc Humbert
Publikováno v:
European Respiratory Review, Vol 30, Iss 162 (2021)
Pulmonary hypertension (PH) confers a significant challenge in perioperative care. It is associated with substantial morbidity and mortality. A considerable amount of information about management of patients with PH has emerged over the past decade.
Externí odkaz:
https://doaj.org/article/4a5b263047c84c4dba47f990004c4b5c
Autor:
Alexandra Cerón-Vivas, Yolanda Gamarra, Maryory Villamizar, Ricardo Restrepo, Reynaldo Arenas
Publikováno v:
Tecnología y ciencias del agua, Vol 10, Iss 6, Pp 90-116 (2019)
El Santuario de Fauna y Flora de Iguaque (SFFI) es un área protegida por Parques Nacionales Naturales de Colombia (SPNN), perteneciente a la región andina colombiana, que abarca ecosistemas de páramo y bosque andino. El objetivo de este trabajo fu
Externí odkaz:
https://doaj.org/article/e99510677b1c452ba5275719b665f594